BiomX (PHGE) Liabilities and Shareholders Equity (2018 - 2026)

BiomX has reported Liabilities and Shareholders Equity for 9 years, with the latest figure at $3.3 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 92.88% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.3 million (down 66.32% YoY) and the FY2025 annual result came in at $5.8 million, down 86.62% from the prior year.
• Liabilities and Shareholders Equity slipped to $3.3 million in Q1 2026 per PHGE's latest filing, from $5.8 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $68.7 million in Q1 2022 and troughed at $3.3 million in Q1 2026.
• A 5-year average of $40.4 million and a median of $41.4 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2024 and 2026: Liabilities and Shareholders Equity surged 81.45% in 2024, then sank 92.88% in 2026.
• Over 5 years, Liabilities and Shareholders Equity stood at $45.5 million in 2022, then sank by 45.03% to $25.0 million in 2023, then jumped by 72.73% to $43.2 million in 2024, then slumped by 86.62% to $5.8 million in 2025, then slumped by 43.78% to $3.3 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $3.3 million, $5.8 million, and $26.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.